MoneyWorks4Me

Marksans Pharma - Quaterly Results

12 Nov 2024 Evaluate
A decent increase of about 50.79% in the turnover to Rs. 3086.25 millions was observed for the quarter ended September 2024. The turnover stood at Rs. 2046.73 millions during the similar quarter previous year.The company almost doubled its revenue to Rs. 632.04 millions  from Rs. 312.89 millions in the quarter ended September 2024.Operating profit for the quarter ended September 2024 rose to 836.29 millions as compared to 532.30 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3086.25 2046.73 50.79 5631.52 3867.14 45.62 8532.73 6552.04 30.23
Other Income 313.57 159.31 96.83 395.09 485.54 -18.63 620.73 604.82 2.63
PBIDT 836.29 532.30 57.11 1330.47 1126.11 18.15 2020.08 1523.85 32.56
Interest 2.76 2.31 19.48 5.59 4.93 13.39 9.88 36.13 -72.65
PBDT 833.53 529.99 57.27 1324.88 1121.18 18.17 2010.20 1487.72 35.12
Depreciation 70.16 84.98 -17.44 138.52 132.22 4.76 291.28 167.37 74.03
PBT 763.37 445.01 71.54 1186.36 988.96 19.96 1718.92 1320.35 30.19
TAX 131.33 132.12 -0.60 234.17 234.16 0.00 381.34 291.69 30.73
Deferred Tax 5.22 15.36 -66.02 4.48 42.30 -89.41 6.78 -1.71 -496.49
PAT 632.04 312.89 102.00 952.19 754.80 26.15 1337.58 1028.66 30.03
Equity 453.16 453.16 0.00 453.16 453.16 0.00 453.16 45316.00 -99.00
PBIDTM(%) 27.10 26.01 4.19 23.63 29.12 -18.87 23.67 23.26 1.79
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..